Life After Woodcock: US FDA Drug Center’s Leadership Transition

 
• By Michael McCaughan
Woodcock_Janet_1200x675
COVID-19 initiatives mark the third time Woodcock has moved up into the commissioner’s office since she first became CDER director in 1994.

More from US FDA

More from Agency Leadership